請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/28025
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 陳秀熙(Hsiu-Hsi Chen) | |
dc.contributor.author | Yi-Ying Wu | en |
dc.contributor.author | 吳怡瑩 | zh_TW |
dc.date.accessioned | 2021-06-12T18:34:11Z | - |
dc.date.available | 2007-08-08 | |
dc.date.copyright | 2007-08-08 | |
dc.date.issued | 2007 | |
dc.date.submitted | 2007-08-01 | |
dc.identifier.citation | References
1. Miniño AM, Heron MP, Smith BL. Deaths: Preliminary Data for 2004. National Vital Statistic Reports 2006;54:1-50. 2. Phipps SMO, Woodfin WK, Tollefsbol TO. The Epigenetics of Breast Carcinogenesis and Metastasis. Current Genomics 2005;6:129-35. 3. Feinberg AP, Tycko B. The history of cancer epigenetics. Nature Reviews 2004;Cancer. 4:143-53. 4. FUKATA H, MORI C. Epigenetic alteration by the chemical substances, food and environmental factors. Reproductive Medicine and Biology 2004;3:115-21. 5. Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, Vogel V, Robidoux A, Dimitrov N, Atkins J, Daly M, Wieand S, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.[see comment]. Journal of the National Cancer Institute 1998;90:1371-88. 6. Claus EB. Risk models used to counsel women for breast and ovarian cancer: a guide for clinicians. Familial Cancer 2001;1:197-206. 7. Freedman AN, Seminara D, Gail MH, Hartge P, Colditz GA, Ballard-Barbash R, Pfeiffer RM. Cancer risk prediction models: a workshop on development, evaluation, and application. Journal of the National Cancer Institute 2005;97:715-23. 8. Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, Mulvihill JJ. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.[see comment]. Journal of the National Cancer Institute 1989;81:1879-86. 9. Gail MH, Costantino JP. Validating and improving models for projecting the absolute risk of breast cancer.[comment]. Journal of the National Cancer Institute 2001;93:334-5. 10. Spiegelman D, Colditz GA, Hunter D, Hertzmark E. Validation of the Gail et al. model for predicting individual breast cancer risk.[see comment]. Journal of the National Cancer Institute 1994;86:600-7. 11. Rockhill B, Spiegelman D, Byrne C, Hunter DJ, Colditz GA. Validation of the Gail et al. Model of Breast Cancer Risk Prediction and Implications for Chemoprevention. J. Natl. Cancer Inst. 2001;93:358-66. 12. Rosner B, Colditz GA. Nurses' health study: log-incidence mathematical model of breast cancer incidence. Journal of the National Cancer Institute 1996;88:359-64. 13. Colditz GA, Rosner B. Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses' Health Study. American Journal of Epidemiology 2000;152:950-64. 14. Barlow WE, White E, Ballard-Barbash R, Vacek PM, Titus-Ernstoff L, Carney PA, Tice JA, Buist DSM, Geller BM, Rosenberg R, Yankaskas BC, Kerlikowske K. Prospective breast cancer risk prediction model for women undergoing screening mammography.[see comment]. Journal of the National Cancer Institute 2006;98:1204-14. 15. Claus EB, Risch N, Thompson WD. Genetic analysis of breast cancer in the cancer and steroid hormone study. American Journal of Human Genetics 1991;48:232-42. 16. Couch FJ, DeShano ML, Blackwood MA, Calzone K, Stopfer J, Campeau L, Ganguly A, Rebbeck T, Weber BL. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer.[see comment]. New England Journal of Medicine 1997;336:1409-15. 17. Berry DA, Parmigiani G, Sanchez J, Schildkraut J, Winer E. Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history.[see comment]. Journal of the National Cancer Institute 1997;89:227-38. 18. Parmigiani G, Berry D, Aguilar O. Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. American Journal of Human Genetics 1998;62:145-58. 19. Antoniou AC, Pharoah PDP, McMullan G, Day NE, Stratton MR, Peto J, Ponder BJ, Easton DF. A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes. British Journal of Cancer 2002;86:76-83. 20. Antoniou AC, Pharoah PPD, Smith P, Easton DF. The BOADICEA model of genetic susceptibility to breast and ovarian cancer.[see comment]. British Journal of Cancer 2004;91:1580-90. 21. Tyrer J, Duffy SW, Cuzick J. A breast cancer prediction model incorporating familial and personal risk factors.[see comment][erratum appears in Stat Med. 2005 Jan 15;24(1):156]. Statistics in Medicine 2004;23:1111-30. 22. Crosier M, Scott D, Wilson RG, Griffiths CD, May FE, Westley BR. Differences in Ki67 and c-erbB2 expression between screen-detected and true interval breast cancers. Clinical Cancer Research 1999;5:2682-8. 23. Chen TH, Kuo HS, Yen MF, Lai MS, Tabar L, Duffy SW. Estimation of sojourn time in chronic disease screening without data on interval cases. Biometrics 2000;56:167-72. 24. Risch HA, McLaughlin JR, Cole DEC, Rosen B, Bradley L, Fan I, Tang J, Li S, Zhang S, Shaw PA, Narod SA. Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada.[see comment]. Journal of the National Cancer Institute 2006;98:1694-706. 25. Saunders CL, Begg CB. Kin-cohort evaluation of relative risks of genetic variants. Genetic Epidemiology 2003;24:220-9. 26. Mandelblatt J, Schechter CB, Lawrence W, Yi B, Cullen J. The SPECTRUM population model of the impact of screening and treatment on U.S. breast cancer trends from 1975 to 2000: principles and practice of the model methods. Journal of the National Cancer Institute 2006;Monographs.:47-55. 27. Dempster A, Laird N, D R. Maximam likelihood from incomplete data via the EM algorithm. Journal of the Royal Statistical Society. Series B 1977;39:1-38. 28. Schroeder JC, Weinberg CR. Use of missing-data methods to correct bias and improve precision in case-control studies in which cases are subtyped but subtype information is incomplete. American Journal of Epidemiology 2001;154:954-62. 29. Illustrated Breast Imaging Reporting and Data System ( BI-RADSTM), 4th ed.ed., vol. 4: American College of Radiology, 2003. 30. Elston RC, Stewart J. A general model for the genetic analysis of pedigree data. Human Heredity 1971;21:523-42. 31. Ott J. Estimation of the recombination fraction in human pedigrees: efficient computation of the likelihood for human linkage studies. American Journal of Human Genetics 1974;26:588-97. 32. Hsieh H-J, Chen TH-H, Chang S-H. Assessing chronic disease progression using non-homogeneous exponential regression Markov models: an illustration using a selective breast cancer screening in Taiwan. Statistics in Medicine 2002;21:3369-82. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/28025 | - |
dc.description.abstract | 除一般遺傳機制外,尚有基因外機制如:DNA甲基化,可在沒有DNA突變的情況下改變基因的表現。如:c-erbB2是一個已知的乳癌基因外因子。和乳癌有關的危險因子一共包含遺傳因子與環境因素,先前也有很多預測模式針對乳癌風險的估計。其缺點在於這些模式被分類為二階段模式而非可以描述疾病進展的三階段模式。故在本研究中,我們建立了三階段馬可夫模式來描述乳癌從正常、臨床前期到臨床期的自然史,也整合了遺傳、基因外因素與環境因子來描述疾病的進展。我們利用模擬的實証資料設計一個實驗來達成這個目標。而研究人員可應用三階段模式於遺傳諮詢上,在給定父母所處之疾病狀態時,估計子代帶有BRCA1或BRCA2基因的機率。最後,在處理疾病狀態位於臨床前期或臨床期不明的情況,可使用EM演算法來處理。 | zh_TW |
dc.description.abstract | In addition to genome influence, epigenetic mechanism, like DNA methylation, is an alterative genetic mechanism which may lead to heterogeneous genotype expression in the absence of DNA mutation. It was well known that c-erbB2 is one of epigenetic factors responsible for breast cancer. The risk factors in association with breast cancer include genetic and environmental factors. There are a number of predicted models for estimating the risk of breast cancer. The drawback is that they are all classified as two-state models rather than multi-state models which can delineate multi-states disease progression in related to genetic and environmental factors. In the present study, we constructed a three-state Markov model to depict breast cancer nature history from normal, preclinical, and to clinical phases. Genetic, epigenetic, and environmental factors obtained from literature are incorporated into model to assess their influences on disease progression. By simulating empirical data, we designed a hypothetical study to show how to achieve this object. The application of three-state model in genetic counseling enables one to estimate the probability of carrying BRCA1 or BRCA2 given information on parents’ disease states. Finally, to deal with the uncertainty about whether disease status is in pre-clinical or clinical phase EM algorithm was applied. | en |
dc.description.provenance | Made available in DSpace on 2021-06-12T18:34:11Z (GMT). No. of bitstreams: 1 ntu-96-R94846004-1.pdf: 1011525 bytes, checksum: 308993d624222201def66820ff908481 (MD5) Previous issue date: 2007 | en |
dc.description.tableofcontents | 口試委員會審定書
誌謝 中文摘要 英文摘要 第一章 前言與研究目的 1 第二章 文獻探討 3 2.1 遺傳因素與環境因子於乳癌之影響 3 2.2 風險模式的種類 3 2.2.1 估計乳癌得病機率 3 2.2.2計算帶有突變基因的機率 6 第三章 研究方法 9 3.1 步驟一:建立三階段模式 10 3.2 步驟二:利用電腦微模擬建立文獻所得實証世代 12 3.3 步驟三:乳癌三階段研究設計與應用 19 3.4 步驟四:家族資料應用於多階段模式 19 3.5 無法分類發病個案位於疾病進展階段之資料處理方法 22 第四章 結果 24 4.1 模擬資料樣本數 24 4.2 模擬結果與假設參數比對 26 4.3 三階段模式研究設計與應用 26 4.4 家族資料應用於三階段模式 40 4.5 利用EM algorithm處理”無法分類”疾病階段資料之結果 44 第五章 討論 46 | |
dc.language.iso | zh-TW | |
dc.title | 遺傳基因、基因外因素與個人因子於多階段乳癌之預測 | zh_TW |
dc.title | Prediction of Multi-State Breast Cancer with Incorporation of Genetic, Epigenetic Factors and Personal Attributes | en |
dc.type | Thesis | |
dc.date.schoolyear | 95-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 戴政,張淑惠(Shu-Hui Chang),林明薇 | |
dc.subject.keyword | 遺傳,基因外因素,多階段預測模式, | zh_TW |
dc.subject.keyword | genetic,epigenetic,multi-state predicted model,EM algorithm, | en |
dc.relation.page | 53 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2007-08-01 | |
dc.contributor.author-college | 公共衛生學院 | zh_TW |
dc.contributor.author-dept | 預防醫學研究所 | zh_TW |
顯示於系所單位: | 流行病學與預防醫學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-96-1.pdf 目前未授權公開取用 | 987.82 kB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。